Circulating Cell-Free Tumour DNA in the Management of Cancer

With the development of new sensitive molecular techniques, circulating cell-free tumour DNA containing mutations can be identified in the plasma of cancer patients. The applications of this technology may result in significant changes to the care and management of cancer patients. Whilst, currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Glenn, Stein, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490543/
https://www.ncbi.nlm.nih.gov/pubmed/26101870
http://dx.doi.org/10.3390/ijms160614122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490543/
https://www.ncbi.nlm.nih.gov/pubmed/26101870
http://dx.doi.org/10.3390/ijms160614122

Ejemplares similares